Algert Global’s Bio-Rad Laboratories Class A BIO Stock Holding History

Algert Global’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$505K	Buy	+1,720	New	+$488K	0.01%	1069
2020 Q2	–	Sell	-1,515	Closed	-$531K	–	423
2020 Q1	$531K	Sell	1,515 -3,135	-67%	-$1.15M	0.22%	161
2019 Q4	$1.72M	Sell	4,650 -3,124	-40%	-$1.1M	0.51%	67
2019 Q3	$2.59M	Hold	7,774	–	–	0.96%	14
2019 Q2	$2.43M	Buy	+7,774	New	+$2.33M	0.9%	20
2019 Q1	–	Sell	-2,014	Closed	-$468K	–	316
2018 Q4	$468K	Buy	+2,014	New	+$540K	0.13%	229
2015 Q4	–	Sell	-2,230	Closed	-$300K	–	330
2015 Q3	$300K	Sell	2,230 -620	-22%	-$89.2K	0.17%	217
2015 Q2	$429K	Sell	2,850 -4,380	-61%	-$627K	0.24%	164
2015 Q1	$977K	Hold	7,230	–	–	0.54%	45
2014 Q4	$872K	Hold	7,230	–	–	0.52%	64
2014 Q3	$820K	Buy	7,230 +1,840	+34%	+$218K	0.61%	46
2014 Q2	$645K	Sell	5,390 -5,220	-49%	-$637K	0.42%	90
2014 Q1	$1.36M	Buy	10,610 +6,010	+131%	+$770K	0.54%	55
2013 Q4	$569K	Hold	4,600	–	–	0.15%	201
2013 Q3	$541K	Hold	4,600	–	–	0.16%	196
2013 Q2	$516K	Buy	+4,600	New	+$540K	0.16%	185

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Algert Global's BIO Position: Q2 2026 in Review

Algert Global opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 1,720 shares worth $505K. The stake represents 0.01% of the portfolio and ranks #1069 among its holdings. This is a return to the name: Algert Global previously reported a position in BIO as recently as Q1 2020.

Algert Global first reported a position in BIO in Q2 2013 and has held it in 16 quarters since. The position peaked at $2.59M in Q3 2019. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Algert Global held 1,720 shares of Bio-Rad Laboratories Class A worth $505K as of Q2 2026.
Bio-Rad Laboratories Class A was a new Algert Global position in Q2 2026.
Bio-Rad Laboratories Class A made up 0.01% of Algert Global's portfolio in Q2 2026, its #1069 holding.
Algert Global first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 16 quarters since.
Algert Global's Bio-Rad Laboratories Class A position peaked at $2.59M in Q3 2019.
398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.